Test Description

What is an Acetaminophen Level?

A serum acetaminophen (APAP, paracetamol) level is a quantitative measurement of drug concentration in the blood. It is the single most important lab test in suspected acetaminophen overdose, as it determines whether antidote therapy with N-acetylcysteine (NAC) is indicated.

Metabolism and Toxicity

At therapeutic doses, acetaminophen is metabolized primarily through glucuronidation and sulfation (approximately 90%). A small fraction (approximately 5-10%) is oxidized by cytochrome P450 (primarily CYP2E1) to the reactive metabolite N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is rapidly conjugated with glutathione and excreted harmlessly.

In overdose, glucuronidation and sulfation pathways become saturated, shunting more drug through the CYP2E1 pathway. When glutathione stores are depleted (below approximately 30% of normal), NAPQI accumulates and binds to hepatocyte proteins, causing centrilobular hepatic necrosis.

The Role of NAC

N-acetylcysteine works by:

  • Replenishing glutathione stores to conjugate NAPQI
  • Serving as a direct glutathione substitute
  • Enhancing sulfation of acetaminophen
  • Providing anti-inflammatory and antioxidant effects in established liver injury
NAC is most effective when given within 8 hours of ingestion. Effectiveness declines after 8 hours, but NAC should still be given regardless of delay — it provides benefit even in established hepatotoxicity.
Quick Reference
  • Therapeutic Range: 10-30 μg/mL
  • Toxic Level (at 4h): ≥150 μg/mL on Rumack-Matthew nomogram
  • Maximum Daily Dose: 4 g/day (2 g/day in liver disease or chronic alcohol use)
  • Toxic Single Dose: >150 mg/kg or >7.5 g in adults
  • Draw Level At: 4 hours post-ingestion (earlier levels are unreliable)
  • Antidote: N-acetylcysteine (NAC) — IV or oral
  • Key Point: APAP is the most common cause of acute liver failure in the US; early NAC is nearly 100% effective if given within 8 hours
Normal Reference Ranges
Swipe to see more
Category Level (μg/mL) Clinical Significance
Therapeutic 10-30 μg/mL Normal analgesic/antipyretic range
Nomogram treatment line (4h) 150 μg/mL Original Rumack-Matthew line; NAC indicated above
Lower treatment line (4h) 100 μg/mL Used by many US centers as more conservative threshold
Potentially lethal (4h) >300 μg/mL High risk of severe hepatotoxicity without treatment
The Rumack-Matthew nomogram is ONLY valid for acute single ingestions at 4+ hours post-ingestion. It is NOT valid for chronic/repeated supratherapeutic ingestion (RSTI), extended-release formulations, unknown time of ingestion, or co-ingestions that delay gastric emptying.
Clinical Significance

Stages of Acetaminophen Toxicity

Stage I (0-24 hours): Pre-Injury

  • Often asymptomatic or mild nonspecific symptoms
  • Nausea, vomiting, malaise, diaphoresis
  • Labs may be entirely normal
  • This is the critical window for NAC — treatment is most effective here

Stage II (24-72 hours): Hepatic Injury

  • AST/ALT begin to rise (can reach >10,000 IU/L)
  • Right upper quadrant pain and tenderness
  • PT/INR begins to rise
  • Renal function may decline (direct tubular toxicity)
  • Initial GI symptoms may briefly improve (deceptive improvement)

Stage III (72-96 hours): Maximum Hepatotoxicity

  • Peak AST/ALT (can exceed 10,000 IU/L)
  • Coagulopathy (INR >2, often >6 in severe cases)
  • Hepatic encephalopathy, jaundice
  • Lactic acidosis, hypoglycemia
  • Acute kidney injury (25-50% of severe cases)
  • Multi-organ failure and death in worst cases

Stage IV (4-14 days): Recovery or Death

  • Survivors show gradual hepatic recovery
  • Complete histologic recovery expected (liver regeneration)
  • Chronic hepatic sequelae are rare in survivors
King's College Criteria for liver transplant evaluation in APAP-induced ALF: Arterial pH <7.30 after resuscitation OR all three of: INR >6.5, creatinine >3.4 mg/dL, and Grade III/IV encephalopathy.

Treatment with NAC

IV Protocol (Prescott, 21-hour):

  • Loading: 150 mg/kg IV over 60 minutes
  • Second infusion: 50 mg/kg IV over 4 hours
  • Third infusion: 100 mg/kg IV over 16 hours

Modified 2-bag protocol (commonly used):

  • 200 mg/kg IV over 4 hours, then 100 mg/kg IV over 16 hours
  • Reduced anaphylactoid reaction rate compared to traditional 3-bag

Oral Protocol (Smilkstein, 72-hour):

  • Loading: 140 mg/kg orally
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses
Interpretation Guidelines

Using the Rumack-Matthew Nomogram

  1. Determine time of ingestion — must be a single acute ingestion with known time
  2. Draw APAP level at 4+ hours post-ingestion — levels before 4 hours cannot be plotted
  3. Plot the level on the nomogram — if above the treatment line, start NAC
  4. If level is below treatment line and patient is asymptomatic — observation and medical clearance

When the Nomogram CANNOT Be Used

  • Repeated supratherapeutic ingestion (RSTI): Chronic overuse — check APAP level AND hepatic panel; treat with NAC if APAP detectable with elevated AST/ALT
  • Unknown time of ingestion: Check APAP level and AST/ALT; start NAC empirically if significant level detected
  • Extended-release formulations: Draw levels at 4 hours and again at 8 hours; treat if either above line
  • Co-ingestion with anticholinergics or opioids: May delay peak absorption; consider repeat level
Always check an APAP level on every overdose patient. Acetaminophen is present in hundreds of combination products. Patients may not know they ingested it. An occult APAP overdose missed on initial evaluation is a preventable cause of liver failure.
Interfering Factors

Factors That Increase Risk of Toxicity

  • Chronic alcohol use: CYP2E1 induction increases NAPQI production; depleted glutathione stores
  • CYP2E1-inducing medications: Isoniazid, rifampin, phenobarbital, carbamazepine, phenytoin
  • Malnutrition/eating disorders: Depleted glutathione reserves
  • Fasting state: Reduced glutathione synthesis
  • Pre-existing liver disease: Reduced hepatic reserve (though APAP metabolism may actually decrease)

Factors That May Cause Falsely Elevated Levels

  • High bilirubin: May cause false elevation on some colorimetric assays
  • N-acetylcysteine: Can interfere with some APAP assays

Important Consideration

An undetectable APAP level does NOT rule out toxicity if the ingestion occurred many hours prior. By the time the patient presents late, the drug may be fully metabolized — but the toxic metabolite (NAPQI) has already caused damage. Always check hepatic function panel if late presentation is suspected.

Clinical Pearls
"Check an APAP level on every overdose": Acetaminophen is in over 600 OTC and prescription products (Vicodin, Percocet, NyQuil, Excedrin). Patients often do not realize what they have taken. A missed APAP overdose is a preventable disaster.
The "4-hour rule": Never plot a level drawn before 4 hours on the nomogram — absorption may not be complete and a sub-toxic level could be falsely reassuring. If the patient presents before 4 hours, wait and draw at the 4-hour mark.
The "deceptive improvement": Patients often feel better during Stage II (24-48h) as nausea resolves, but liver injury is actively progressing. Never discharge based on symptom improvement alone — follow LFTs and INR.
Activated charcoal: Most effective if given within 1-2 hours of ingestion. Consider if presenting within 4 hours and no contraindications (intact airway, cooperative, not vomiting). Does NOT replace NAC.
NAC anaphylactoid reactions: Occur in approximately 10-20% of patients receiving IV NAC (flushing, urticaria, bronchospasm). These are dose-rate dependent and usually occur during the loading dose. Slow the infusion, give antihistamines — do NOT stop NAC. The reaction is not a true allergy.
Acetaminophen is the #1 cause of acute liver failure in the US, surpassing all other causes combined. Approximately 50% of cases are unintentional, often from taking multiple APAP-containing products simultaneously.
When in doubt, treat with NAC. NAC is extremely safe and the consequences of withholding treatment in a true overdose are catastrophic. If there is any question about timing, amount ingested, or reliability, start NAC and reassess.
References
  1. Rumack, B. H., & Matthew, H. (1975). Acetaminophen poisoning and toxicity. Pediatrics, 55(6), 871-876.
  2. Heard, K. J. (2008). Acetylcysteine for acetaminophen poisoning. New England Journal of Medicine, 359(3), 285-292.
  3. Farkas, Josh MD. (2015). Acetaminophen toxicity. EMCrit Project — Internet Book of Critical Care.
  4. Lee, W. M. (2017). Acetaminophen (APAP) hepatotoxicity — Isn't it time for APAP to go away? Journal of Hepatology, 67(6), 1324-1331.
  5. Nickson, C. (n.d.). Paracetamol toxicity. Life in the Fast Lane (LITFL).
Back to Toxicology Panel All Lab Values
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.